GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gian Life Care Ltd (BOM:542918) » Definitions » EV-to-EBIT

Gian Life Care (BOM:542918) EV-to-EBIT : 3.86 (As of Jun. 01, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Gian Life Care EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gian Life Care's Enterprise Value is ₹227.2 Mil. Gian Life Care's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ₹58.8 Mil. Therefore, Gian Life Care's EV-to-EBIT for today is 3.86.

The historical rank and industry rank for Gian Life Care's EV-to-EBIT or its related term are showing as below:

BOM:542918' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.98   Med: 9.06   Max: 46.38
Current: 3.86

During the past 6 years, the highest EV-to-EBIT of Gian Life Care was 46.38. The lowest was 2.98. And the median was 9.06.

BOM:542918's EV-to-EBIT is ranked better than
92.31% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.24 vs BOM:542918: 3.86

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Gian Life Care's Enterprise Value for the quarter that ended in Sep. 2024 was ₹284.2 Mil. Gian Life Care's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ₹58.8 Mil. Gian Life Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 20.69%.


Gian Life Care EV-to-EBIT Historical Data

The historical data trend for Gian Life Care's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gian Life Care EV-to-EBIT Chart

Gian Life Care Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial 3.32 1.58 6.88 8.13 3.89

Gian Life Care Quarterly Data
Mar19 Jun19 Sep19 Mar20 Sep20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.95 8.60 3.89 3.64 4.83

Competitive Comparison of Gian Life Care's EV-to-EBIT

For the Diagnostics & Research subindustry, Gian Life Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gian Life Care's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gian Life Care's EV-to-EBIT falls into.


;
;

Gian Life Care EV-to-EBIT Calculation

Gian Life Care's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=227.183/58.801
=3.86

Gian Life Care's current Enterprise Value is ₹227.2 Mil.
Gian Life Care's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹58.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gian Life Care  (BOM:542918) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Gian Life Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=58.801/284.175
=20.69 %

Gian Life Care's Enterprise Value for the quarter that ended in Sep. 2024 was ₹284.2 Mil.
Gian Life Care's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹58.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gian Life Care EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Gian Life Care's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Gian Life Care Business Description

Traded in Other Exchanges
N/A
Address
7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The Company has only one operating segment namely, Laboratories Pathological Investigations.

Gian Life Care Headlines

No Headlines